EMBioSys
The Future of Cancer Therapy is Wearable.
https://wefunder.com/embiosys
Total raised on Wefunder: 0
Total investors: 0
Quick facts
- Efinia™ is a novel, patented, scalable platform technology representing a large market opportunity
- $2.65 Million in non-dilutive funding awarded to date from the National Cancer Institute
- Experienced cross-functional team and business partners
- Compelling pre-clinical evidence and peer reviewed publications
- Excellent safety profile: Non-invasive, low power, no adverse events in pre-clinical studies
- Standard distribution path from demand...to order...to patient
- Product design & manufacturing activities completed with inventory to support human clinical trials
- Clear clinical development plan to reach product launch in an area of high unmet medical need